Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 437 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 160 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 2, wobei auf jede offiziell registrierte Infektion etwa 253 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 5.659 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 18 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 05.11.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
SARS-CoV-2 exposure in deer increases with use of human-modified habitat 04.11.2026
Integrated Molecular and Serological Epizootic Monitoring of SARS-CoV-2 and Influenza A Virus in Animals in Kazakhstan 04.11.2026
PABbind:A Hierarchical Geometric Framework for Mutation-Involved Antigen−Antibody Interaction Prediction and SARS-CoV-2 Immune Escape Assessment 04.11.2026
Introducing SARS-CoV-2 wastewater surveillance in Lebanon 04.11.2026
Timing dependent associations of acute phase laboratory and antibody parameters with post-acute sequelae of SARS-CoV-2 infection in unvaccinated individuals 04.11.2026
Результаты клинического испытания рекомбинантной вакцины против Омикрон-Дельта штаммов SARS-CoV-2 04.11.2026
Serologic and clinical correlates of within-host SARS-CoV-2 genetic diversity in a large acute-infection cohort 04.11.2026
Endocrine and Metabolic Characteristics and Prognosis of Long COVID Following SARS-CoV-2 Infection During the Omicron Period 04.11.2026
How Did the Clinical Presentation of COVID-19 in Children Change Across SARS-CoV-2 Variants? A Systematic Review 04.11.2026
Correction to “Long COVID across SARS‐CoV‐2 variants:Clinical features, pathogenesis, and future directions” 04.11.2026
Persistent left ventricular systolic dysfunction at ≥6 months after SARS-CoV-2–associated MIS-C:a systematic review and rare-event meta-analysis 04.11.2026
Living with SARS-CoV-2:A 6-year reflection on the pandemic’s ongoing impact and future implications 04.11.2026
<b>COMPUTATIONAL IDENTIFICATION OF IMMUNOMODULATORY NATURAL COMPOUNDS AS POTENTIAL MULTI-TARGET INHIBITORS OF SARS-COV-2 PROTEINS:MOLECULAR DOCKING, PHARMACOKINETIC AND ACUTE TOXICITY PROFILING</b> 04.11.2026
Assessment of SARS-CoV-2 RNA Stability in Residual Samples:Impact of Long-Term -80°C Storage and Room Temperature on Ct Values. 04.11.2026
A Refined Search of SARS-CoV-2 Main Protease Inhibitors as COVID-19 Antivirals 04.11.2026
Clustering Genetically Closely Related SARS-CoV-2 Lineages that Share the Same Relative Effective Reproduction Number Using BIC–Based Model Selection 04.11.2026
Living with SARS-CoV-2:A 6-year reflection on the pandemic's ongoing impact and future implications. 03.11.2026
Relationship between Profile, Quality of Life and Burden of Older People With Dementia's Caregivers during the COVID-19 Pandemic. 03.11.2026
Bovine-Associated Viruses at the Human-Animal Interface:Zoonotic Risks, Spillover Dynamics, and One Health Implications. 03.11.2026
Changes in self-reported Long COVID in different variant-dominant phases of the SARS-CoV-2 pandemic:the influence of vaccination on a diverse Israeli cohort study. 03.11.2026
Long COVID prevalence among U.S. adults:A state-level ecological analysis of associations with SARS-CoV-2 incidence, COVID-19 hospitalization rates, COVID-19 vaccine coverage, and multimorbidity. 03.11.2026
eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression. 03.11.2026
Epigenetic aging during the COVID-19 pandemic:A prospective longitudinal study with prepandemic baseline data in children, adolescents, and adults. 03.11.2026
Non-covalent inhibitors targeting SARS-CoV-2 3CLpro:structural insights and developmental landscape. 03.11.2026
Therapeutic opportunities of marine-derived bioactive compounds against SARS-CoV-2 and other enveloped viruses. 03.11.2026
In vitro antioxidant, anti-inflammatory, antifungal, and anti-HCoV-229E activities of Jatropha integerrima leaf and stem bark extract and in vivo evaluation of its intravenous SNEDDS in a mouse model. 03.11.2026
Multi-virus Wastewater Surveillance in Heterogeneous Urban-Sewage Systems:Comparative Insights From Sewage Treatment Plants and Open Drains. 03.11.2026
Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1. 03.11.2026
Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered spike localization and increased cell-to-cell transmission. 03.11.2026
Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity. 03.11.2026
Modeling the cost-effectiveness of NVX-CoV2705 and the public health impact of vaccination for the prevention of seasonal COVID-19 in the US. 03.11.2026
Post-ARDS Pulmonary Fibrosis:From Molecular Mechanisms to Clinical Management. 03.11.2026
03.11.2026
Structure-Guided Design and Functional Validation in Cultured Cells of Gapmers Targeting SARS-CoV-2 RNA 03.11.2026
Inhibiting the interaction between the mitochondrial receptor Tom70 and SARS CoV 2 Orf9b with small molecules 03.11.2026
Changes in self-reported Long COVID in different variant-dominant phases of the SARS-CoV-2 pandemic:the influence of vaccination on a diverse Israeli cohort study 03.11.2026
Long COVID prevalence among U.S. adults:A state-level ecological analysis of associations with SARS-CoV-2 incidence, COVID-19 hospitalization rates, COVID-19 vaccine coverage, and multimorbidity 03.11.2026
397 B220 + Ly6C + MHCII + cells mobilized by SARS-CoV-2 mRNA vaccine promote CD8 + T cell priming and sensitize tumors to immune checkpoint blockade 03.11.2026
388 SARS-CoV-2 mRNA vaccination enhances responses to dual PD-1 and CTLA-4 blockade and is associated with expansion of antigen-specific CD8 + T-cell clonotypes 03.11.2026
873 Non-tumor specific SARS-CoV-2 mRNA vaccines prime the immune system for enhanced immune checkpoint inhibitor efficacy 03.11.2026
770 T cell cross-reacting to SARS-CoV-2 viral antigens and TAAs via molecular mimicry 03.11.2026
Otimização da produção de antígenos de SARS-CoV-2 em cultivo de células Expi293F visando a geração de vacinas baseadas em OMVs. 03.11.2026
Honeybee (Apis mellifera) venom and its bioactive peptides tertiapin and apamin modulate the proteome of SARS-CoV-2-infected cells 03.11.2026
Giám sát SARS-CoV-2 trong nước thải tại Hà Nội giai đoạn 2021–2024:Áp dụng hệ thống giám sát môi trường vi rút bại liệt 03.11.2026
Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered spike localization and increased cell-to-cell transmission 03.11.2026
Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish 03.11.2026
SARS-CoV-2 S1 oqsilini Saccharomyces cerevisiae hujayralarida rekombinant ekspressiya qilishni baholash 03.11.2026
ASSOCIATIONS BETWEEN SARS-COV-2 INFECTION, COVID-19 VACCINATION, AND AMYOTROPHIC LATERAL SCLEROSIS 03.11.2026
Cryptic spread of SARS-CoV-2 undermined targeted travel restrictions 03.11.2026
Retrospective and Bibliometric Assessment of SARS-CoV-2 Viral Culture (2020–2025):Navigating Five Years of Technological Shifts, Translational Research and Viral Immune Evasion 03.11.2026
Polyaniline-based fluorescence nucleic acid biosensor for SARS-COV-2 RNA monitoring:from analytical validation to wastewater analysis 03.11.2026
Assessing the Age-Specific Seroepidemiology of Varicella-Zoster Virus in Korea in the Post-COVID-19 Era Using an Acetone-Fixed Cell FAMA Assay. 02.11.2026
Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026
Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026
Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival. 01.11.2026
SARS-CoV-2 exposure in deer increases with use of human-modified habitat. 01.11.2026
Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026
Catalyst-free synthesis of imidazol-4-ylphosphonates from N-arylamidines and diisopropyl (chloroethynyl)phosphonate. 28.10.2026
Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026
SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026
Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026
Fangchinoline as a Dual-action Therapeutic Agent:Recent Advances in Cancer and Infectious Disease Research. 21.10.2026
The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026
Depression, anxiety, and stress at different time frames in relation to COVID-19 disease course:a Flemish observational study. 20.10.2026
Analysis of multiplex pathogen sentinel surveillance results of SARS-CoV-2 and influenza virus in Sichuan Province, 2024-2026. 20.10.2026
Single-cell profiling of dysfunctional NK cells in COVID-19:from immunization to acute infection and beyond. 20.10.2026
Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026
Changes in epidemiology and antibiotic resistance patterns isolated from paediatric urinary tract infections:a multicenter study in China pre-, during and post-COVID-19. 19.10.2026
Outcome measures in long COVID clinical trials:a review. 19.10.2026
Longitudinal immune trajectories following SARS-CoV-2 vaccination in long-term care facility residents:an unsupervised analysis approach. 19.10.2026
T-cell recognition of SARS-CoV-2 antigen peptides following booster vaccination with mRNA and viral-vectored COVID-19 vaccines. 19.10.2026
Antibody afucosylation and enhanced autoreactive antibody response are associated with thyroid dysfunction during severe SARS-CoV-2 infection. 19.10.2026
Inflammatory and immunologic analysis of bronchoalveolar lavage from patients with post-COVID-19 lung disease. 19.10.2026
Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature. 19.10.2026
The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026
Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026
Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026
Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026
Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026
SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026
SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026
The WHO interim Medical Countermeasures Network for public health emergencies. 08.10.2026
Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026
Social inequalities in SARS-CoV-2 infection in France:An intersectional analysis 01.10.2026
Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:Quanta Profiles and Infection Control. 01.10.2026
Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026
The other immune landscape of SARS-CoV-2 evolution. 28.09.2026
Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026
Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026
Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026
Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026
Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026
A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026
Incidence of new-onset pulmonary fibrosis 4.5 years post SARS-CoV-2 infection in an academic urban medical center. 07.08.2026
Effect of pirfenidone on the short- and long-term outcomes in pulmonary infection-related acute respiratory distress syndrome:a prospective cohort study. 05.08.2026
The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026
Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026
Prevalence of SARS-COV-2 infection, Relationship between SARS-CoV-2 and HIV among Sex Workers in Cotonou. 01.08.2026
Quellen: PubMed, Europe PMC & CrossRef
Embolo und Xhaka zurück in der Nati: Yakin sieht bei einem von beiden noch «Gesprächsbedarf» - 20 Minuten 05.11.2026
Erkältung: Diese Erreger kursieren im Spätherbst – wo das Risiko am höchsten ist - WELT 05.11.2026
Gesundheitsreferat startet in der Ludwigsvorstadt Impfaktion ohne Termin gegen Grippe und Corona - TZ 05.11.2026
Corona: Neue Studie enthüllt, was bei Menschen mit schweren Langzeitfolgen anders ist - WELT 05.11.2026
Neue Regeln für Corona-Impfung: Was sich ändert und warum - SWR 04.11.2026
Corona: China antwortet mit Milliarden-Klage auf US-Urteil - Table.Briefings 04.11.2026
Diese Marler Apotheken impfen gegen Grippe und Covid: Termine und Beratung vor Ort - Marler Zeitung 04.11.2026
Myokarditis: COVID-19-Impfung zeigt deutlich günstigeres Risikoprofil als Infektion - Biermann Medizin 03.11.2026
Wer zahlt für die Corona-Impfung? Ein Beschluss verändert die Regeln grundlegend. - T-Online 03.11.2026
Studie zu Post-COVID-Syndrom zeigt Potenzial von Cortison - RTF.1 Regionalfernsehen 02.11.2026
Symposium zu Long COVID - Mittelhessen 02.11.2026
Long-Covid-Kolumne: Liegen mit ME/CFS ist kein Ausruhen, sondern ein Zwang des Körpers - Apotheken Umschau 02.11.2026
Wie verbreitet ist das Coronavirus aktuell in Bayern? Das zeigen aktuelle Abwasser-Daten - Augsburger Allgemeine 02.11.2026
Long Covid mit Hirntraining behandeln: Was steckt dahinter? - SRF 30.10.2026
Covid-19-Impfstoff nicht mehr für alle auf Kassenkosten: Neue Regeln gelten - Pnp.de 30.10.2026
Covid-19, Influenza, RSV: Impfprogramm 2.0 für den Herbst - Pharmazeutische Zeitung 29.10.2026
COVID-19 - Auswärtiges Amt 22.10.2026
Warum Krankenkassen die Impfung mit aktuellem Corona-Impfstoff nicht bezahlen - MDR.de 06.10.2026
Homepage | Reha-Angebot für COVID-19-Erkrankte - Deutsche Rentenversicherung 20.05.2026
Homepage | Eckpunktepapier für die medizinische Rehabilitation bei Post-COVID-Syndrom - Deutsche Rentenversicherung 20.05.2026
Quelle: Google News
Für Regen gibt es Radar, für Viren jetzt eine Ampel. Die neue Virenampel zeigt auf einen Blick, welche Atemwegserkrankungen gerade verbreitet sind.
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.